FDA approves Neuralstem's stem cell trial

09/21/2009 | Chicago Tribune (tiered subscription model)

Neuralstem has received FDA approval to test the safety of injecting neural stem cells into the spinal cords of patients with amyotrophic lateral sclerosis, or Lou Gehrig's disease. Dr. Eva Feldman, a University of Michigan neurologist, will serve as the principal investigator of the clinical trial, which will be conducted at Emory University in Atlanta.

View Full Article in:

Chicago Tribune (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Deputy Director, Marketing
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Director of Operations - GBS
Mayo Clinic
MN
Director of Actuarial Services, Government Programs
PacificSource
OR
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC